West Oak Capital, LLC - SYROS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
West Oak Capital, LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$01500.0%0.00%
Q4 2021$0150
+50.0%
0.00%
Q3 2021$0
-100.0%
1000.0%0.00%
Q2 2021$1,0001000.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,139,895$23,486,0004.50%
Samsara BioCapital, LLC 2,189,199$14,769,0002.72%
Bain Capital Life Sciences Investors, LLC 5,785,036$43,272,0002.45%
Omega Fund Management, LLC 1,562,500$11,688,0001.11%
Flagship Pioneering Inc. 2,938,494$21,980,0000.35%
EcoR1 Capital, LLC 1,000,000$7,480,0000.33%
Altium Capital Management LP 126,702$948,0000.26%
Nikko Asset Management Americas, Inc. 5,042,009$37,714,0000.18%
Artal Group S.A. 1,025,000$7,667,0000.14%
Orbimed Advisors 1,837,500$13,745,0000.13%
View complete list of SYROS PHARMACEUTICALS INC shareholders